DrugPatentWatch Database Preview
VALTOCO Drug Profile
» See Plans and Pricing
When do Valtoco patents expire, and what generic alternatives are available?
Valtoco is a drug marketed by Neurelis Inc and is included in one NDA. There are five patents protecting this drug.
This drug has sixty-five patent family members in eighteen countries.
The generic ingredient in VALTOCO is diazepam. There are eight drug master file entries for this compound. Thirty-nine suppliers are listed for this compound. Additional details are available on the diazepam profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Valtoco
A generic version of VALTOCO was approved as diazepam by MYLAN on September 4th, 1985.
Summary for VALTOCO
| International Patents: | 65 |
| US Patents: | 5 |
| Applicants: | 1 |
| NDAs: | 1 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for VALTOCO |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for VALTOCO |
| What excipients (inactive ingredients) are in VALTOCO? | VALTOCO excipients list |
| DailyMed Link: | VALTOCO at DailyMed |
US Patents and Regulatory Information for VALTOCO
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Neurelis Inc | VALTOCO | diazepam | SPRAY;NASAL | 211635-001 | Jan 10, 2020 | RX | Yes | No | Start Trial | Start Trial | Y | Start Trial | |||
| Neurelis Inc | VALTOCO | diazepam | SPRAY;NASAL | 211635-003 | Jan 10, 2020 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | |||
| Neurelis Inc | VALTOCO | diazepam | SPRAY;NASAL | 211635-001 | Jan 10, 2020 | RX | Yes | No | Start Trial | Start Trial | Start Trial | ||||
| Neurelis Inc | VALTOCO | diazepam | SPRAY;NASAL | 211635-001 | Jan 10, 2020 | RX | Yes | No | Start Trial | Start Trial | Y | Start Trial | |||
| Neurelis Inc | VALTOCO | diazepam | SPRAY;NASAL | 211635-002 | Jan 10, 2020 | RX | Yes | No | Start Trial | Start Trial | Y | Start Trial | |||
| Neurelis Inc | VALTOCO | diazepam | SPRAY;NASAL | 211635-003 | Jan 10, 2020 | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | ||||
| Neurelis Inc | VALTOCO | diazepam | SPRAY;NASAL | 211635-002 | Jan 10, 2020 | RX | Yes | No | Start Trial | Start Trial | Y | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for VALTOCO
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Japan | 5752048 | Start Trial |
| European Patent Office | 2271347 | Start Trial |
| South Korea | 20110099049 | Start Trial |
| Russian Federation | 2554814 | Start Trial |
| European Patent Office | 3082817 | Start Trial |
| Australia | 2009228093 | Start Trial |
| Japan | 2019163273 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
